Neurontin (gabapentin) capsules are now approved for use as add-on therapy for partial epilepsy in children aged six years and above. Also, revisions have been made to the posology and administration, undesirable effects and pharmacokinetic properties sections of the summary of product characteristics, says Parke-Davis.